Dermoscopy May Provide a More Accurate Diagnosis of Mycosis Fungoides
Dermoscopic features of mycosis fungoides (MF) variants are investigated.
Mycosis Fungoides
Does Quinine Potentiate Antimicrobial Blue Light Therapy in Patients With Cutaneous Mold Infection?
Investigators conducted a study to determine the effects of quinine hydrochloride in combination with antimicrobial blue light therapy in patients with cutaneous mold infection.
Skin Manifestations of Systemic Cancers
Dermatoses of the skin, and their relevance to the early detection of many systemic forms of cancer, are reviewed.
Psoriasis and Risk for Lympho-Hematological Malignancies
The association between psoriasis and lympho-hematological malignancies in 25 observational cohort studies is evaluated.
Head and Neck Involvement in Mycosis Fungoides Influences Prognosis
The link between head and neck involvement on the clinicoprognostic features of mycosis fungoides (MF) is evaluated.
Cutaneous Stage Predictive of Survival in Folliculotropic Mycosis Fungoides
Does a new cutaneous staging system for folliculotropic mycosis fungoides (FMF) better estimate survival compared with the staging system for conventional disease?
Chronic Inflammatory Skin Diseases Associated with Hospitalization for Herpes Zoster
Patients with chronic inflammatory skin diseases (CISD) are at increased risk for significant morbidity from herpes zoster.
Recommendations for Managing Cutaneous Lymphoma During COVID-19
A new guideline provides strategies for managing patients with primary cutaneous lymphoma during the COVID-19 pandemic.
Combination Bexarotene, Photochemotherapy Effective for Cutaneous T-Cell Lymphoma in Asian Patients
A novel study investigated the safety and efficacy of combination bexarotene and photochemotherapy for the treatment of cutaneous T-cell lymphoma in Asian patients.
Lymphomatoid Papulosis: Better Prognosis Than Previously Reported, Yet Associated Malignancies
Although the frequency of associated HM is lower than suggested and the prognosis of most patients with associated HM is excellent, a small subgroup of patients will develop aggressive disease. Patients with LyP also have a higher risk for developing other malignancies.
- Loading...
Loading...
Next post in General Dermatology
Loading... 
Loading...